mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer

Extensive preclinical studies have identified mammalian target of rapamycin (mTOR) activation as a frequent molecular signature underlying head and neck squamous cell carcinoma (HNSCC), including the distinct clinical subtype that is human papillomavirus (HPV) related, and have demonstrated the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppock, Joseph D., Lee, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2016
Materias:
Novel discoveries/Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698505/
https://www.ncbi.nlm.nih.gov/pubmed/29204551
http://dx.doi.org/10.1016/j.wjorl.2016.05.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698505/
https://www.ncbi.nlm.nih.gov/pubmed/29204551
http://dx.doi.org/10.1016/j.wjorl.2016.05.010

Ejemplares similares